This week on Pharma Research VIDEO Report:
1) Experts agree the promise of comparative effectiveness research is having very little impact on healthcare decision making. 2) Dr. David Bates researched Big Data algorithms that he says can positively impact the expenditures on low-hanging fruit with in-patients. 3) The FDA must make a decision on whether or not to continue Mini-Sentinel, a program that queries 18 health plan and insurance partners about patient records that can show adverse events.
Google Flu Trends overstates U.S. influenza; CMS pushes Medicare Part D data release; PharmaGuy, John Mack, discusses pharmaco new MR technology usage; FDA finds new adverse event information source (PRVR–3/24 – 3/28/2014)
On this week’s Pharma Research VIDEO Report:
1) There has been successful social media-sourced tracking of contagious diseases, but the Google Flu Trends has overestimated the spread of influenza in the U.S. in 2011-2012 and 2012-2013, according to Time Magazine.
2) Center for Medicare & Medicaid Services is pushing ahead part of its proposed Part D changes that deal with release of data to reputable organizations doing legitimate work. It has health care insurance coverage implications.
3) Pharmaguy John Mack joins PRVR to discuss what he says happening with pharma market research.
4) The FDA’s search for adverse events has led it to support creation of software that allows it to access 100 million health insurance and health records.
RFL Communications, Inc. 